Jacqualyn A. Fouse
2021 - Agios Pharmaceuticals
Compensation breakdown
Non-Equity Incentive Plan | $543,400 |
---|---|
Option Awards | $5,202,524 |
Salary | $760,000 |
Other | $13,503 |
Total | $6,519,427 |
Fouse received $5.2M in option awards, accounting for 80% of the total pay in 2021.
Fouse also received $543.4K in non-equity incentive plan, $760K in salary and $13.5K in other compensation.
Rankings
In 2021, Jacqualyn A. Fouse's compensation ranked 1,920th out of 12,412 executives tracked by ExecPay. In other words, Fouse earned more than 84.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,920 | 85th |
Manufacturing | 725 | 87th |
Chemicals And Allied Products | 277 | 88th |
Drugs | 236 | 89th |
Pharmaceutical Preparations | 156 | 90th |
Pay ratio
Jacqualyn A. Fouse's Pay | $6,519,427 |
---|---|
Median Employee's Pay | $315,091 |
Pay Ratio | 21to 1 |
In 2021, the annual total compensation of Jacqualyn A. Fouse was $6,519,427.
The annual total compensation of the median employee at Agios Pharmaceuticals was $315,091.
The ratio of Jacqualyn A. Fouse's pay to the pay of median employee was therefore 21 to one.
Fouse's colleagues
We found six more compensation records of executives who worked with Jacqualyn A. Fouse at Agios Pharmaceuticals in 2021.
2021
Jonathan Biller
Agios Pharmaceuticals
Chief Financial Officer
2021
Bruce Car
Agios Pharmaceuticals
Chief Scientific Officer
2021
Christopher Bowden
Agios Pharmaceuticals
Chief Medical Officer
2021
Darrin Miles
Agios Pharmaceuticals
Former Chief Commercial Officer
2021
Sarah Gheuens
Agios Pharmaceuticals
Chief Medical Officer
2021
Richa Poddar
Agios Pharmaceuticals